Targeting adenosine monophosphate-activated protein kinase (AMPK) in preclinical models reveals a potential mechanism for the treatment of neuropathic pain

• Main Authors: Peebles Katherine A (Author), Johnson Jessica (Author), Khoutorsky Arkady (Author), Lark Arianna (Author), Yan Jin (Author), Sanoja Raul (Author), Tillu Dipti V (Author), Asiedu Marina N (Author), Melemedjian Ohannes K (Author), Lepow Talya (Author), Sonenberg Nahum (Author), Dussor Gregory (Author), Price Theodore J (Author)
• Format: Book
• Published: SAGE Publishing, 2011-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

<p>Abstract</p> <p>Neuropathic pain is a debilitating clinical condition with few efficacious treatments, warranting development of novel therapeutics. We hypothesized that dysregulated translation regulation pathways may underlie neuropathic pain. Peripheral nerve injury induced r...